P
PAK BioSolutions
Design of advanced equipment for the manufacture of biopharmaceutical products
About PAK BioSolutions
PAK BioSolutions is a company that specializes in the manufacture of biopharmaceuticals. They offer comprehensive solutions for the continuous production of these products, which are medicines made using biological processes. The company's unique selling point is its ability to increase productivity while reducing capital costs and space requirements. This is achieved through their proprietary PAK System, a piece of equipment that can continuously purify large volumes of cell culture, a crucial step in biopharmaceutical production.
PAK BioSolutions serves clients in the biopharmaceutical industry, which includes companies that develop and produce medicines derived from living organisms. This market is growing rapidly due to the increasing demand for such medicines, which are often more effective and have fewer side effects than traditional drugs.
The company's business model is based on selling, leasing, or providing demos of their PAK System. They also offer custom quotes for their services, which suggests a degree of customization to meet the specific needs of their clients. The company is also compliant with 21 CFR Part 11, a regulation that sets the standards for electronic records and signatures, and uses USP Class VI materials, which are safe for use in medical applications.
In terms of revenue, PAK BioSolutions makes money by selling or leasing their PAK System and providing related services. They also generate income by offering courses and participating in industry events.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- Vienna, United States
- Employees
- 19
- Open positions
- None listed
- Dealroom signal
- 85.7/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Techbio, DT and LS, science-based
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jun 2024 | $12M | $48M | BroadOak Capital Partners · Arboretum Ventures | ↗ |
| OtherOther financing | Jun 2023 | $0 | — | BioTools Innovator | ↗ |
Growth signals
Latest recorded traffic for PAK BioSolutions is 410 monthly website visits, down 62.7% over the last three months. PAK BioSolutions's team grew 46.2% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Arboretum Ventures- BPBroadOak Capital Partners
Other known investors1 additional known investor
BioTools Innovator
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about PAK BioSolutions on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See PAK BioSolutions’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







